Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Eledon Pharmaceuticals Inc (ELDN)

Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Eledon Pharmaceuticals Inc 19900 MACARTHUR BOULEVARD SUITE 550 IRVINE CA 92612 USA

www.eledon.com P: 949-238-8090

Description:

Eledon Pharmaceuticals Inc. is a clinical stage biotechnology company. It develop treatments for an organ or cell-based transplant, and for people with autoimmune and neurodegenerative disease. Eledon Pharmaceuticals Inc., formerly known as Novus Therapeutics Inc., is based in IRVINE, Calif.

Key Statistics

Overview:

Market Capitalization, $K 61,040
Enterprise Value, $K 56,430
Shares Outstanding, K 24,813
Annual Sales, $ 0 K
Annual Net Income, $ -40,330 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -10,300 K
EBIT, $ -42,760 K
EBITDA, $ -42,390 K
60-Month Beta 0.91
% of Insider Shareholders 11.70%
% of Institutional Shareholders 56.77%
Float, K 21,910
% Float 88.30%
Short Volume Ratio 0.74

Growth:

1-Year Return 80.88%
3-Year Return -67.63%
5-Year Return -84.29%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 94.16%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.34 on 05/09/24
Next Earnings Date 08/08/24
Earnings Per Share ttm -1.38
EPS Growth vs. Prev Qtr -17.24%
EPS Growth vs. Prev Year 54.67%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-18 on 10/05/20

ELDN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -45.60%
Return-on-Assets % -42.76%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.82
Book Value/Share 3.02
Interest Coverage -2.18
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar